바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 의과대학-내과학교실, 호흡기내과, 호흡기내과, 폐암센터

전문진료분야

  • <호흡기내과> 폐암, 폐종양, 폐기능 검사, 기관지 내시경, 항암 화학요법, 목표 치료제 (토요진료- 5주째만 진료)

진료시간표

인터넷진료예약
의사시간표
진료시간
오전 통상진료 통상진료 통상진료
오후 통상진료

교육 및 임상 경력

  • 세브란스  병원  수련의  및  전공의 
  • 강남  세브란스  병원  강사
  • 내과  전문의  및  호흡기  분과  전문의 
  • 용인세브란스  병원  전임강사
  • 강남세브란스  병원  전임강사
  • 강남세브란스  병원  조교수  및  응급실  차장
  • 강남세브란스  병원  IRB  위원회  위원
  • 국민연금관리공단  호흡기  자문의
  • 호흡기내과장  (110901~  150301)
  • 현  강남세브란스병원  호흡기내과  교수

학술관련경력

  • 대한 내과학회 정회원
  • 결핵 및 호흡기 학회 정회원
  • 대한 폐암학회 정회원
  • Active Member of American Association for Cancer Research

주요 관심분야

  • 폐암의 발생 기전, 성장과 약물 치료,폐종양, 폐기능 검사, 기관지 내시경, 항암 화학요법, 목표 치료제

학력사항

  • 연세대학교 의과대학 의학과
  • 연세대학교 의과대학 대학원 의학과 석사
  • 연세대학교 의과대학 대학원 의학과 박사
  • Post-Doc Fellow at M.D. Anderson Cancer Center

논문

  • i. Jeon JH, Kim SK, Kim HJ, Chang J, Ahn CM, Chang YS*. Insulin-like growth factor-1 attenuates cisplatin-induced γH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer. Cancer Letters 2008 Dec; 272(2):232-41.
  • ii. Lee CY, Jeon JH, Kim HJ, Shin DH, Roh TW, Ahn CM, Chang YS*. Clinical Significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis. Korean J Int Med 2008 Sep; 23(3):116-120.
  • iii. Lim JY, Cho JY, Paik YH, Chang YS*, Kim HG. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Biol Markers 2007 Oct-Dec;22(4):281-6.
  • iv. Chang YS*, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer Lung Cancer 2007 Sep; 57(3):370-80.
  • v. Haam SJ, Chang YS*, Kim HJ, Lee DY, Paik HC, Chun SE. Photodynamic therapy for endobronchial obstruction due to recurrent lung cancer ? 2 case report. J of Lung Cancer 2007 Jun; 6(1):35-7.
  • vi. Lee CY, Chung JH, Chang YS*, Kim SK, Kim HJ, Chang J, Kim SK, Ahn CM, Clinical features of patients with lung cancer and upper aerodigestive tract cancer. Tuberc Respir Dis 2007 Apr;62(4):284-289.
  • vii. Jung HY, Lee CY, Kim HJ, Ahn CM, Chang YS*. A case of subnugal abscess and onycholysis induced by docetaxel. Tuberc Respir Dis 2007 Feb;62(2):125-128.
  • viii. Park MS, Chang YS*, Shin JH, Kim DJ, Chung KY, Shin DH, Moon JW, Kang SM, Hahn CH, Kim YS, Chang J, Kim SK, Kim SK. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J. 2007 Feb 28;48(1):69-77
  • ix. Lee CY, Ahn CM, Jeon JH, Kim HY, Kim SK, Chang J, Kim SK, Chang YS*. Association of insulin receptor substrate-1 G972R variant with non-small cell lung cancer risk. Journal of Lung disease. 2006 Dec; 1(1); 22-27.
  • x. Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS*. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Oncol Rep. 2006 Dec;16(6):1205-10.
  • xi. Kim Y, Chang YS*, Kim HJ, Kim SK, Chang J, Ahn CM, Kim SK, Kwak JY, Choi JH. Alteration of coagulation and fibrinolysis system according to right ventiricular dysfunction in chronic obstructive pulmonary disease. Tuberc Respir Dis 2006 Jun;60(6):625-630.
  • xii. Chang YS*, Cho JY, Cho HA, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. 9-cis Retinoic Acid Induces Insulin-like Growth Factor Binding Protein-3 through DR-8 Retinoic Acid Responsive Elements. Cancer Biol Ther. 2006 Jun;5(6):586-92.
  • xiii. Moon JW, Chang YS*, Ahn CW, Yoo KN, Shin JH, Kong JH, Kim YS, Chang J, Kim SK, Kim HJ, Kim SK. Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk. Int J Cancer. 2006 Jan 15;118(2):353-6.
  • xiv. Cho JY, Paik YH, Chang YS*, Lee SJ, Lee DK, Song SY, Chung JB, Park MS, Yu JS, Yoon DS. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer. 2005 Dec 15;104(12):2753-8.
  • xv. Moon JW, Chang YS*, Kim SK, Kim YS, Lee HM, Kim SK, Chang J. The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis. Clin Infect Dis. 2005 Sep 1;41(5):660-6.
  • xvi. Lee HY, Chang YS*, Han JY, Liu DD, Lee JJ, Lotan R, Spitz MR, Hong WK. Effects of 9-cis-Retinoic Acid on the Insulin-Like Growth Factor Axis in Former Smokers. J Clin Oncol. 2005 Jul 1;23(19):4439-49.
  • xvii. Chang JH, Kim DY, Kim Y, Chang YS*, Kim HJ, Ahn CM, Kim SK, Kim TH. A case of pulmonary injury induced by accidental exposure to high level of nitrogen dioxide. J Korean Soc Clin Toxicol. 2005 Jun;3(1):40-4.
  • xviii. Lee JS, Kim DY, Hwang SJ, Baek SS, Chang YS*, Kim HJ, Ahn CM. A case of pulmonary embolism occurred after injection of bovine collagen. Korean J Med. 2005 68(5):581-6.
  • xix. Chang YS*. Dyspnea in the elderly. Korean J Clin Geriatr 2005 Apr; 6(1):81-9.
  • xx. Kim DY, Kim YK, Kim Y, Chang YS*, Kim HJ, Ahn CM, Ryu YH. A case of primary pericardial malignant mesothelioma. Tuberc Respir Dis 2004 Dec;57(6):599-603.
  • xxi. Chang YS*, Kim Y, Kim DY, Kim HJ, Ahn CM, Lee DY, Paik HC. Two cases of post-transplant lymphoproliferative disorder in lung transplant recipients. Korean J Int Med 2004 Dec; 19(4):276-81.
  • xxii. Kim DY, Lee JS, Kim Y, Chang YS*, Kim HJ, Kim TH, Ahn CM. A case of isolated right pulmonary artery agenesis. Tuberc Respir Dis 2004 Nov;57(5):489-93.
  • xxiii. Lee HY, Moon H, Chun KH, Chang YS*, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK. Effects of insulin-like growth factor binding protein-3 and farnesyl transferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells. J Natl Cancer Inst 2004 Oct 20;96(20):1536-48.
  • xxiv. Park JS, Chang YS*, Yoo KN, Nam JY, Kim CS, Kim DM, Cho MH, Park J, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. Relations between IGFBP-3 promoter polymorphism and body composition parameters and obesity. J Korean Society Study Obesity 2004 Sep; 13(3):187-94.
  • xxv. Yoo YD, Cho SM, Kim JS, Chang YS*, Ahn CM, Kim HJ. The human myotubularin-related protein suppresses the growth of lun*g carcinoma cells. Oncol Rep 2004 Sep;12(3):667-71.
  • xxvi. Chang YS*, Wang L, Suh YA, Mao L, Karpen SJ, Khuri FR, Hong WK, Lee HY. Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer. Oncogene 2004 Aug 26;23(*39):6569-80.
  • xxvii. Chang YS*, Chung JH, Shin DH, Chung KY, Kim YS, Chang J, Kim SK, Kim SK. Retinoic acid receptor-β expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Yonsei Med J 2004 Jun. 30; 45(3):435-42.
  • xxviii. Kee HJ, Shin JH, Chang J, Chung KY, Shim DH, Kim YS, Chang YS*, Kim SK, Kwak SM, Kim SK. Identification of tumor suppressor loci on the short arm of chromosome 16 in primary small cell lung cancer. Tuberc Respir Dis 2003 Dec 55(6):72-81.
  • xxix. Moon C, Soria JC, Jang SJ, Lee J, Hoque MO, Sibony M, Trink B, Chang YS*, Sidransky D, Mao L. Involvement of aquaporins in colorectal carcinogenesis. Oncogene 2003 Oct 2;22(43):6699-703.
  • xxx. Chang YS*, Wu W, Walsh G, Hong WK, Mao L. Enolase-α is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clin Cancer Res 2003. Sep.1;9(10 pt 1):3641?4.
  • xxxi. Chang YS*, Kim Y, Lee CY, Choi JR, Kim HJ, Ahn CM, Kim SK. Clinical meaning of INNO-LiPA test in the diagnosis of rifampin resistance tuberculosis. Tuberc Respir Dis 2003. Oct 55(4), 344-52.
  • xxxii. Wang L, Soria JC, Chang YS*, Lee HY, Wei Q, Mao, L. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene 2003 Oct 2;22(43):6699-703.
  • xxxiii. Soria JC, Moon C, Kemp BL, Liu DD, Feng L, Tang X, Chang YS*, Mao L, Khuri FR. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 2003 May;9(5):1785-91.
  • xxxiv. Chang YS*, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee H-Y. Clinical significance of IGFBP-3 expression in stage I non-small cell lung cancer. Clin Cancer Res 2002 Dec;8(12):3796-802.
  • xxxv. Chang YS*, Wang L, Liu D, Mao L, Khuri FR, Hong WK, Lee H-Y. Correlation between IGFBP-3 promoter hypermethylation and Prognosis of Patients with Stage I Non-Small Cell Lung Cancer. Clin Cancer Res. 2002 Dec;8(12):3669-75.
  • 항생제 사용 중 발생한 기계 호흡기 관련 폐렴에서 기관지 폐포 세척술의 진단적 의미
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 49/1 :72-81,2000
  • 좌측 주기관지에 발생한 연골종 1례
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 48/1 :78-83,2000
  • 원발성 소세포암에서 Microsatellite 분석을 이용한 Microsatellite불안정화에 대한 연구
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 48/2 :180-190,2000
  • Clinical significance of IGFBP-3 expression in stage I non-small cell lung cancer
    CLINICAL CANCER RESEARCH 8/12 :3796-3802,2002
  • Correlation between IGFBP-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    CLINICAL CANCER RESEARCH 8/12 :3669-3675,2002
  • Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer
    CLINICAL CANCER RESEARCH 9/5 :1785-1791,2003
  • Association of a functional tandem repeats in the downstream of human telemoerase gene and lung cancer
    ONCOGENE 22/46 :7123-7129,2003
  • Involvement of aquaporins in colorectal carcinogenesis
    ONCOGENE 22/43 :6699-6703,2003
  • Enolase-alpah is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior
    CLINICAL CANCER RESEARCH 9/10 :3641-3644,2003
  • 고립성 우측 폐동맥 형성부전증 1례
    이달의 X선 57/5 :489-493,2004
  • 신체지표 및 비만도의 결정 요인으로서 IGFBP-3 Promoter Polymorphism
    대한비만학회지(Journal Of Korean Oriental Association For Study Of Obesity) 13/3 :187-194,2004
  • 원발성 악성 심막 중피종 1예
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 57/6 :599-603,2004
  • Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat
    NEUROSCIENCE LETTERS 360/ :129-132,2004
  • Mechanisms underlying lack of inulin-like growth factor-binding protein- expression in non-small-celllung cancer
    ONCOGENE 23/ :6569-6580,2004
  • Retinoic acid receptor-β expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium
    YONSEI MEDICAL JOURNAL 45/3 :435-442,2004
  • The human myotubularin-related protein suppresses the growth of lung carcinoma cells
    ONCOLOGY REPORTS 12/ :667-671,2004
  • 원발성 소세포폐암에서 염색체 16번의 단완에 위치한 종양억제유전자좌의 확인
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 55/6 :597-611,2004
  • Rifampin 내성 결핵의 진단에서 INNO-LiPA 검사법의 임상적 의미
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 55/4 :-,2004
  • Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers
    JOURNAL OF CLINICAL ONCOLOGY 23/19 :4439-4449,2005
  • 인슐린양 성장 인자 결합 단백-3 유전자 -202 좌위의 다형성에 따른 비소세포폐암의 의험도
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 58/4 :359-366,2005
  • The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis
    CLINICAL INFECTIOUS DISEASES 41/ :660-666,2005
  • 고농도의 이산화질소(NO2)흡입으로 유발된 급성 폐손상 1례
    대한임상독성학회지 3/1 :40-44,2005
  • 우형 콜라겐 주사 후에 발생한 폐색전증 1예
    대한내과학회지(korean Journal of medcine) 68/5 :581-586,2005
  • Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
    CANCER 104/ :2753-2758,2005
  • 9-cis retinoic acid induces insulin-like growth factor binding protein-3 through DR-8 retinoic acid responsive elements
    CANCER BIOLOGY & THERAPY 5/6 :586-592,2006
  • Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk
    INTERNATIONAL JOURNAL OF CANCER 118/ :353-356,2006
  • Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer
    ONCOLOGY REPORTS 16/ :1205-1210,2006
  • Association of Insulin Receptor Substrate-1 G972R variant with Non-Small Cell Lung Cancer Risk
    Journal of Lung Disease 1/1 :22-27,2006
  • 만성폐쇄성폐질환에서 우심실 기능 부전에 따른 혈액응고 및 섬유소용해계 변화
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 60/6 :625-630,2006
  • Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer
    LUNG CANCER 57/3 :373-380,2007
  • The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients
    YONSEI MEDICAL JOURNAL 48/1 :69-77,2007
  • Docetaxel 투여 후 발생한 조갑하 농양 및 조갑 박리증 1예
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 62/2 :125-128,2007
  • 폐암과 상부소화호흡기암이 동반된 환자의 경우 임상적 특징
    결핵 및 호흡기질환(Tuberculosis And Respiratory Diseases) 62/ :284-289,2007
  • Photodynamic therapy for endobronchial obstruction due to recurrent lung cancer - 2 cases report -
    Journal of Lung Cancer 6/1 :35-37,2007
  • Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 22/4 :281-286,2007
  • Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis
    The Korean Journal Of Internal Medicine 23/3 :116-120,2008
  • Association of insulin receptor substrate-1 G972R variant with non-small cell lung cancer risk
    Tuberculosis And Respiratory Diseases(결핵 및 호흡기질환) 67/1 :8-13,2009
  • 비소세포 폐암환자에서 Docetaxel 투여 중 발생한 아급성 피부 홍반루푸스 1예
    Tuberculosis And Respiratory Diseases(결핵 및 호흡기질환) 66/5 :380-384,2009
  • 전종격동에서 발생한 악성 횡문근양 종양 1예
    Tuberculosis And Respiratory Diseases(결핵 및 호흡기질환) 67/5 :462-466,2009
  • 제1기 비소세포폐암에서 APT1 발현의 임상적 의미
    Tuberculosis And Respiratory Diseases(결핵 및 호흡기질환) 68/4 :212-217,2010
  • Lipid raft modulation inhibits NSCLC cell migration through delocalization of the focal adhesion complex
    Lung Cancer 69/2 :165-171,2010
  • Clinical significance of GADD153 expression in stage I non-small cell lung cancer
    ONCOLOGY LETTERS 4/3 :408-412,2012
  • Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
    YONSEI MEDICAL JOURNAL 53/5 :974-984,2012
  • Comparative Study of Patients in Correct Usage of and Preference for the Swinghaler and Turbuhaler Multidose Inhalers
    JOURNAL OF ASTHMA 49/ :750-756,2012
  • Fiberoptic bronchoscopy for the rapid diagnosis of smear-negative pulmonarytuberculosis
    BMC INFECTIOUS DISEASES 12/1 :141-141,2012
  • Surgical decortication as the first-line treatment for pleural empyema.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY 145/4 :933-939,2013
  • Late respiratory infection after lung transplantation
    Tuberculosis and Respiratory Diseases 74/2 :63-69,2013
  • Notch1 destabilizes the adherens junction complex through upregulation of the Snail family of E-cadherin repressors in non-small cell lung cancer
    ONCOLOGY REPORTS 30/3 :1423-1429,2013
  • 굴곡 기관지 내시경 시술 중 에피네프린 도포 후 발생한 스트레스성 심근병증 2예
    Korean journal of critical care medicine (대한중환자의학회지) 28/2 :127-132,2013
  • A Case of Locally Advanced Well-Differentiated Fetal Adenocarcinoma of the Lung Treated with Concurrent Chemoradiation Therapy
    Tuberculosis and Respiratory Diseases 74/5 :226-230,2013
  • Associations of Moderate to Severe Asthma with Obstructive Sleep Apnea
    YONSEI MEDICAL JOURNAL 54/4 :942-948,2013
  • CT 유도하 경피적 흉부 세침흡인생검 후 발생한 뇌 공기색전증 1예
    대한내과학회지 85/4 :416-419,2013
  • Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells
    RESPIRATORY RESEARCH 15/26 :1-9,2014
  • Whole Blood Interferon-γ Release Assay Is Insufficient for the Diagnosis of Sputum Smear Negative Pulmonary Tuberculosis
    YONSEI MEDICAL JOURNAL 55/3 :725-731,2014
  • KRAS oncogene substitutions in Korean NSCLC patients: Clinical implication and relationship with pAKT and RalGTPases expression
    LUNG CANCER 85/2 :299-305,2014
  • Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
    YONSEI MEDICAL JOURNAL 56/1 :103-111,2015
  • Effects of blood lead levels on airflow limitations in Korean adults: Findings from the 5th KNHNES 2011
    ENVIRONMENTAL RESEARCH 136/0 :274-279,2015
  • AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models
    CANCER LETTERS 358/1 :85-91,2015
  • Diagnostic utility of interferon-gamma release assay in extrapulmonary tuberculosis
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 82/1 :44-48,2015
  • A Rare Case of Primary Thymic Adenocarcinoma Mimicking Small Cell Lung Cancer
    Tuberculosis and Respiratory Diseases 78/2 :112-119,2015
  • Anastomotic Airway Complications after Lung Transplantation
    YONSEI MEDICAL JOURNAL 56/5 :1372-1378,2015
  • BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis
    LUNG CANCER 90/1 :106-110,2015
  • Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma
    BMC CANCER 16/27 :1-9,2016
  • Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
    CANCER BIOLOGY & THERAPY 17/3 :237-245,2016
  • The feasibility of CT lung volume as a surrogate marker of donor?recipient size matching in lung transplantation
    MEDICINE 95/27 :e3957-,2016
  • mechanisms of epidermal growth factor receptor tyrosine kinase inhibitor resistance and strategies to overcome resistance in lung adenocarcinoma
    Tuberculosis and Respiratory Diseases 79/4 :248-256,2016
  • Association of Specific Immunoglobulin E to Staphylococcal Enterotoxin with Airway Hyperresponsiveness in Asthma Patients
    Tuberculosis and Respiratory Diseases 79/4 :295-301,2016
  • Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
    Tuberculosis and Respiratory Diseases 80/1 :52-59,2017
  • ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
    NEOPLASIA 19/4 :354-363,2017
  • Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer
    JOURNAL OF CANCER 8/8 :1,347-1,354,2017
  • Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer.
    BMC CANCER 17/1 :467-475,2017
  • MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    LUNG CANCER 110/ :63-67,2017
  • The repeatability of computed tomography lung volume measurements: Comparisons in healthy subjects, patients with obstructive lung disease, and patients with restrictive lung disease
    PLOS ONE 12/8 :e0182849-,2017
  • Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome
    Tuberculosis and Respiratory Diseases 80/2 :179-186,2017
  • Lessons learned from continued TB outbreaks in a high school
    PLOS ONE 12/11 :e0188076-e0188086,2017
  • Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
    Tuberculosis and Respiratory Diseases 81/1 :19-28,2018
  • Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    JOURNAL OF CANCER 9/6 :1,113-1,120,2018
  • High versus low attenuation thresholds to determine the solid component of ground-glass opacity nodules.
    PLOS ONE 13/10 :205,490-205,497,2018
  • Safety of endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer within a year after percutaneous coronary intervention
    THORACIC CANCER 9/11 :1,390-1,397,2018
  • Stabilization of Cyclin-Dependent Kinase 4 by Methionyl-tRNA Synthetase in p16INK4a-Negative Cancer
    ACS Pharmacology & Translational Science 1/1 :21-31,2018
  • Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
    BMC CANCER 18/ :1,221-1,230,2018

장윤수

진료철학
전세계적으로 매년 1,200, 000예가 발생하고 있는 폐암은 우리 나라에서도 약 5 년 전부터 위암 다음으로 많이 발생하고 있으며 아직까지 암 사망률 1위를 차지하고 있는 중증의 질환입니다. 원내 타과와의 유기적인 협의 진료 하에서 표준화된 수술, 항암화학 요법 및 방사선 요법을 시행하고 있으며 세계적인 유수의 병원과 견주어 손색이 없는 치료 성적을 보이고 있습니다. 폐암에 대한 이해의 증가와 함께 폐암의 예방을 위한 다각적 노력과 특수한 상황에서 적용되는 시술들, 나아가 삶의 질을 높일 수 있는 다양한 보존적 치료들로서 폐암의 치료에 적극적인 노력을 하고 있습니다. 또한 이러한 임상 자료와 경험을 바탕으로 폐암의 발생과 성장 기전의 규명을 통한 예방 및 조기 진단 방법의 개발과 함께 진행된 폐암에 대한 새로운 치료 방법의 연구에도 매진하고 있습니다.

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보